| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.005 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |